Silence Therapeutics plc Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes
Silence Therapeutics plc (SLNCF) reported Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes of GBP 2.23 million for the 12-month period ending 2023-12-31, per its 20-F filed 2024-03-13.
Discontinued › Cash Flow › Operating Activities
ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges · last filed 2024-03-13
| Period end | Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes 12 month |
|---|---|
| 2023-12-31 | 2.23M GBP 20-F · filed 2024-03-13 |
| 2022-12-31 | -18.95M GBP 20-F · filed 2024-03-13 |
| 2021-12-31 | 46.19M GBP 20-F · filed 2024-03-13 |
| 2020-12-31 | 14.27M GBP 20-F · filed 2023-03-15 |
| 2019-12-31 | -8.02M GBP 20-F · filed 2022-03-17 |